Increased expression of PITX2 transcription factor contributes to ovarian cancer progression

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Fung, Frederic K C ^a   Chan, David W ^a   Liu, Vincent W S ^a   Leung, Thomas H Y ^a   Cheung, Annie N Y ^a   Ngan, Hextan Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; TRANSCRIPTION FACTOR PITX2; CCND1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; POLYMERASE CHAIN REACTION; TUMOR GROWTH; WNT SIGNALING; ANIMAL; BIOSYNTHESIS; CANCER INVASION; CELL CYCLE; CELL GROWTH; CELL MOTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE MYC; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BETA CATENIN; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN D1; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HOMEODOMAIN PROTEINS; HUMANS; MICE; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION; WNT PROTEINS;

EID: 84872012295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037076     Document Type: Article

References (32)

1. Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, et al. (2008) Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol 9: 1076–1085.
2. Auersperg N, Maines-Bandiera SL, Dyck HG (1997) Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 173: 261–265.
3. Farley J, Ozbun LL, Birrer MJ (2008) Genomic analysis of epithelial ovarian cancer. Cell Res 18: 538–548.
4. Karst AM, Drapkin R (2010) Ovarian cancer pathogenesis: a model in evolution. J Oncol 2010: 932371.
5. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, et al. (2003) Histological classification of ovarian cancer. Med Electron Microsc 36: 9–17.
6. Amendt BA, Semina EV, Alward WL (2000) Rieger syndrome: a clinical, molecular, and biochemical analysis. Cell Mol Life Sci 57: 1652–1666.
7. Cho KR, Shih Ie M (2009) Ovarian cancer. Annu Rev Pathol 4: 287–313.
8. Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, et al. (2004) Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28: 496–504.
9. Hjalt TA, Semina EV, Amendt BA, Murray JC (2000) The Pitx2 protein in mouse development. Dev Dyn 218: 195–200.
10. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, et al. (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65: 10214–10222.
11. Meeh PF, Farrell CL, Croshaw R, Crimm H, Miller SK, et al. (2009) A gene expression classifier of node-positive colorectal cancer. Neoplasia 11: 1074–1083.
12. Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ (2010) Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2. Cell Cycle 9.
13. Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, et al. (2008) Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29: 1742–1750.
14. Lee YL, Lee KF, Xu JS, Wang YL, Tsao SW, et al. (2001) Establishment and characterization of an immortalized human oviductal cell line. Mol Reprod Dev 59: 400–409.
15. Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, et al. (2011) P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/ calpain-dependent mechanism. Oncogene 30: 4219–4230.
16. Skidmore JM, Cramer JD, Martin JF, Martin DM (2008) Cre fate mapping reveals lineage specific defects in neuronal migration with loss of Pitx2 function in the developing mouse hypothalamus and subthalamic nucleus. Mol Cell Neurosci 37: 696–707.
17. Wang Y, Thakur A, Sun Y, Wu J, Biliran H, et al. (2007) Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice. Cancer Res 67: 3698–3707.
18. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, et al. (2002) Identification of a Wnt/Dvl/beta-CateninRPitx2 pathway mediating cell-type-specific proliferation during development. Cell 111: 673–685.
19. Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347: 1593–1603.
20. Saad AF, Hu W, Sood AK (2010) Microenvironment and pathogenesis of epithelial ovarian cancer. Horm Cancer 1: 277–290.
21. Fukumoto M, Nakayama K (2006) Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma? Pathol Int 56: 233–239.
22. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3–10.
23. Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I (2009) Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 14: 383–391.
24. Kieusseian A, Chagraoui J, Kerdudo C, Mangeot PE, Gage PJ, et al. (2006) Expression of Pitx2 in stromal cells is required for normal hematopoiesis. Blood 107: 492–500.
25. Guioli S, Lovell-Badge R (2007) PITX2 controls asymmetric gonadal development in both sexes of the chick and can rescue the degeneration of the right ovary. Development 134: 4199–4208.
26. Martin DM, Skidmore JM, Fox SE, Gage PJ, Camper SA (2002) Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev Biol 252: 84–99.
27. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, et al. (2006) Target genes of the WNT/beta-catenin pathway in Wilms tumors. Genes Chromosomes Cancer 45: 565–574.
28. Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, et al. (2003) Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci U S A 100: 3245–3250.
29. Rodriguez-Leon J, Rodriguez Esteban C, Marti M, Santiago-Josefat B, Dubova I, et al. (2008) Pitx2 regulates gonad morphogenesis. Proc Natl Acad Sci U S A 105: 11242–11247.
30. Martinez-Fernandez S, Hernandez-Torres F, Franco D, Lyons GE, Navarro F, et al. (2006) Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts. Dev Dyn 235: 2930–2939.
31. Ganga M, Espinoza HM, Cox CJ, Morton L, Hjalt TA, et al. (2003) PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5. J Biol Chem 278: 22437–22445.
32. Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ (2010) Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2. Cell Cycle 9: 1333–1341.